• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逐步开发用于基因传递的仿生嵌合肽。

Stepwise Development of Biomimetic Chimeric Peptides for Gene Delivery.

机构信息

Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

出版信息

Protein Pept Lett. 2020;27(8):698-710. doi: 10.2174/0929866527666200206153328.

DOI:10.2174/0929866527666200206153328
PMID:32026767
Abstract

Gene-based therapy largely relies on the vector type that allows a selective and efficient transfection into the target cells with maximum efficacy and minimal toxicity. Although, genes delivered utilizing modified viruses transfect efficiently and precisely, these vectors can cause severe immunological responses and are potentially carcinogenic. A promising method of overcoming this limitation is the use of non-viral vectors, including cationic lipids, polymers, dendrimers, and peptides, which offer potential routes for compacting DNA for targeted delivery. Although non-viral vectors exhibit reduced transfection efficiency compared to their viral counterpart, their superior biocompatibility, non-immunogenicity and potential for large-scale production make them increasingly attractive for modern therapy. There has been a great deal of interest in the development of biomimetic chimeric peptides. Biomimetic chimeric peptides contain different motifs for gene translocation into the nucleus of the desired cells. They have motifs for gene targeting into the desired cell, condense DNA into nanosize particles, translocate the gene into the nucleus and enhance the release of the particle into the cytoplasm. These carriers were developed in recent years. This review highlights the stepwise development of the biomimetic chimeric peptides currently being used in gene delivery.

摘要

基因治疗在很大程度上依赖于载体类型,这种载体类型允许选择性和高效地转染到靶细胞中,同时最大限度地提高疗效和最小化毒性。虽然利用修饰病毒递送的基因可以有效地进行转染,但是这些载体可能会引起严重的免疫反应,并且具有潜在的致癌性。克服这一限制的一种有前途的方法是使用非病毒载体,包括阳离子脂质体、聚合物、树枝状聚合物和肽,它们为靶向递送的 DNA 提供了潜在的压缩途径。虽然非病毒载体的转染效率比其病毒对应物低,但它们优越的生物相容性、非免疫原性和大规模生产的潜力使它们在现代治疗中越来越有吸引力。人们对仿生嵌合肽的开发产生了浓厚的兴趣。仿生嵌合肽包含不同的基序,用于将基因转染到所需细胞的核内。它们具有将基因靶向到所需细胞的基序,将 DNA 浓缩成纳米大小的颗粒,将基因转染到核内,并增强颗粒向细胞质的释放。这些载体是近年来开发的。本综述重点介绍了目前用于基因传递的仿生嵌合肽的逐步发展。

相似文献

1
Stepwise Development of Biomimetic Chimeric Peptides for Gene Delivery.逐步开发用于基因传递的仿生嵌合肽。
Protein Pept Lett. 2020;27(8):698-710. doi: 10.2174/0929866527666200206153328.
2
Development of novel recombinant biomimetic chimeric MPG-based peptide as nanocarriers for gene delivery: Imitation of a real cargo.新型重组仿生嵌合MPG基肽作为基因递送纳米载体的开发:对真实货物的模仿。
Eur J Pharm Biopharm. 2016 Oct;107:191-204. doi: 10.1016/j.ejpb.2016.06.017. Epub 2016 Jun 28.
3
Nano-biomimetic carriers are implicated in mechanistic evaluation of intracellular gene delivery.纳米仿生载体与细胞内基因传递的机制评估有关。
Sci Rep. 2017 Jan 27;7:41507. doi: 10.1038/srep41507.
4
Functional and biodegradable dendritic macromolecules with controlled architectures as nontoxic and efficient nanoscale gene vectors.具有可控结构的功能生物可降解树枝状大分子作为无毒高效的纳米尺度基因载体。
Biotechnol Adv. 2014 Jul-Aug;32(4):818-30. doi: 10.1016/j.biotechadv.2013.12.008. Epub 2014 Jan 3.
5
A biomimetic lipid library for gene delivery through thiol-yne click chemistry.通过硫醇-炔点击化学进行基因传递的仿生脂质库。
Biomaterials. 2012 Nov;33(32):8160-6. doi: 10.1016/j.biomaterials.2012.07.044. Epub 2012 Aug 16.
6
Current state of the art in peptide-based gene delivery.基于肽的基因传递的最新技术进展。
J Control Release. 2022 Mar;343:600-619. doi: 10.1016/j.jconrel.2022.02.010. Epub 2022 Feb 11.
7
Development of a novel histone H1-based recombinant fusion peptide for targeted non-viral gene delivery.新型基于组蛋白 H1 的重组融合肽用于靶向非病毒基因递送的研究进展。
Int J Pharm. 2013 Jan 30;441(1-2):307-15. doi: 10.1016/j.ijpharm.2012.11.027. Epub 2012 Nov 28.
8
Mesenchymal stem cell fate following non-viral gene transfection strongly depends on the choice of delivery vector.间质干细胞在非病毒基因转染后的命运强烈依赖于递送载体的选择。
Acta Biomater. 2017 Jun;55:226-238. doi: 10.1016/j.actbio.2017.03.044. Epub 2017 Mar 29.
9
Exploring the role of peptides in polymer-based gene delivery.探索肽在基于聚合物的基因递送中的作用。
Acta Biomater. 2017 Sep 15;60:23-37. doi: 10.1016/j.actbio.2017.07.043. Epub 2017 Aug 1.
10
Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.迈向用于基因治疗的人工病毒的开发:病毒转染与非病毒转染的比较评估
Biotechnol Prog. 2008 Jul-Aug;24(4):871-83. doi: 10.1021/bp070319o.

引用本文的文献

1
A novel multi-functional chimeric peptide for enhanced safe gene delivery in immunotherapy.一种用于免疫治疗中增强安全基因递送的新型多功能嵌合肽。
Gene Ther. 2025 Apr 30. doi: 10.1038/s41434-025-00538-5.